Cargando…

Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia

Preeclampsia (PE) is a disorder specific to pregnancy characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. There is no definite treatment for PE except delivery of the placenta. The purpose of this study was to elucidate the biological pathways involved in the develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yong Wook, Shim, Jung In, Shim, So Hyun, Shin, Yun-jeong, Shim, Sung Han, Chang, Sung Woon, Cha, Dong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370049/
https://www.ncbi.nlm.nih.gov/pubmed/30653101
http://dx.doi.org/10.1097/MD.0000000000013971
_version_ 1783394293223784448
author Jung, Yong Wook
Shim, Jung In
Shim, So Hyun
Shin, Yun-jeong
Shim, Sung Han
Chang, Sung Woon
Cha, Dong Hyun
author_facet Jung, Yong Wook
Shim, Jung In
Shim, So Hyun
Shin, Yun-jeong
Shim, Sung Han
Chang, Sung Woon
Cha, Dong Hyun
author_sort Jung, Yong Wook
collection PubMed
description Preeclampsia (PE) is a disorder specific to pregnancy characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. There is no definite treatment for PE except delivery of the placenta. The purpose of this study was to elucidate the biological pathways involved in the development of PE and to discover a novel biomarker for PE by performing global gene expression analysis of amniotic fluid cell-free RNA. The participants were recruited from the Department of Obstetrics and Gynecology of CHA Gangnam Medical Center (Seoul, Korea) between March 2014 and February 2015. Eight samples were collected from 8 subjects at second trimester who were later diagnosed with PE. From the amniotic fluid samples, cell-free RNA extraction was performed and gene expression was analyzed using the GeneChip PrimeView Array. Transcriptome data previously analyzed by our group from 9 euploid mid-trimester amniotic fluid samples were used as the control for comparative analysis. Functional analysis of the probe sets was performed using the online Database for Annotation, Visualization, and Integrated Discovery (DAVID) toolkit 6.7. We identified 1841 differentially expressed genes (DEGs) between the PE group and the control. Of these, 1557 genes were upregulated in the PE group, while 284 genes were upregulated in the control. The functional annotation of DEGs identified specific enriched functions such as “transport,” “signal transduction,” and “stress response.” Functional annotation clustering with enriched genes in the PE group revealed that translation-related genes, cell–cell adhesion genes, and immune-related genes were enriched. KEGG pathway analysis showed that several biological pathways, including the ribosome pathway and various immune pathways, were dysregulated. Several genes, including RPS29, IGF-2, and UBC, were significantly upregulated in PE, up to tenfold. This study provides the first genome-wide expression analysis of amniotic fluid cell-free RNA in PE. The results showed that gene expression involving the ribosome pathway and immunologic pathways are dysregulated in PE. Our results will aid in understanding the underlying pathogenesis of PE.
format Online
Article
Text
id pubmed-6370049
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63700492019-02-22 Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia Jung, Yong Wook Shim, Jung In Shim, So Hyun Shin, Yun-jeong Shim, Sung Han Chang, Sung Woon Cha, Dong Hyun Medicine (Baltimore) Research Article Preeclampsia (PE) is a disorder specific to pregnancy characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. There is no definite treatment for PE except delivery of the placenta. The purpose of this study was to elucidate the biological pathways involved in the development of PE and to discover a novel biomarker for PE by performing global gene expression analysis of amniotic fluid cell-free RNA. The participants were recruited from the Department of Obstetrics and Gynecology of CHA Gangnam Medical Center (Seoul, Korea) between March 2014 and February 2015. Eight samples were collected from 8 subjects at second trimester who were later diagnosed with PE. From the amniotic fluid samples, cell-free RNA extraction was performed and gene expression was analyzed using the GeneChip PrimeView Array. Transcriptome data previously analyzed by our group from 9 euploid mid-trimester amniotic fluid samples were used as the control for comparative analysis. Functional analysis of the probe sets was performed using the online Database for Annotation, Visualization, and Integrated Discovery (DAVID) toolkit 6.7. We identified 1841 differentially expressed genes (DEGs) between the PE group and the control. Of these, 1557 genes were upregulated in the PE group, while 284 genes were upregulated in the control. The functional annotation of DEGs identified specific enriched functions such as “transport,” “signal transduction,” and “stress response.” Functional annotation clustering with enriched genes in the PE group revealed that translation-related genes, cell–cell adhesion genes, and immune-related genes were enriched. KEGG pathway analysis showed that several biological pathways, including the ribosome pathway and various immune pathways, were dysregulated. Several genes, including RPS29, IGF-2, and UBC, were significantly upregulated in PE, up to tenfold. This study provides the first genome-wide expression analysis of amniotic fluid cell-free RNA in PE. The results showed that gene expression involving the ribosome pathway and immunologic pathways are dysregulated in PE. Our results will aid in understanding the underlying pathogenesis of PE. Wolters Kluwer Health 2019-01-18 /pmc/articles/PMC6370049/ /pubmed/30653101 http://dx.doi.org/10.1097/MD.0000000000013971 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Jung, Yong Wook
Shim, Jung In
Shim, So Hyun
Shin, Yun-jeong
Shim, Sung Han
Chang, Sung Woon
Cha, Dong Hyun
Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia
title Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia
title_full Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia
title_fullStr Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia
title_full_unstemmed Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia
title_short Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia
title_sort global gene expression analysis of cell-free rna in amniotic fluid from women destined to develop preeclampsia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370049/
https://www.ncbi.nlm.nih.gov/pubmed/30653101
http://dx.doi.org/10.1097/MD.0000000000013971
work_keys_str_mv AT jungyongwook globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia
AT shimjungin globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia
AT shimsohyun globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia
AT shinyunjeong globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia
AT shimsunghan globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia
AT changsungwoon globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia
AT chadonghyun globalgeneexpressionanalysisofcellfreernainamnioticfluidfromwomendestinedtodeveloppreeclampsia